Ultravist 150
Ultravist 150 is an originator product from Bayer (Schweiz) AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 31.50 to CHF 64.70 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Bayer (Schweiz) AG
- ATC code
- V08AB05
- IT group
- 14.01.13 Niederosmolare nicht-ionische Monomere
- Active substances
- Iodum
- Preparation type
- Originator product
- On the SL since
- 15/03/1994
- Last price change
- 01/12/2024
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Lös 150 mg/ml 50 ml Fl | 1 Stk | CHF 13.88 | CHF 31.50 | 01/02/2025 | B | 7680469690023 |
| Inj Lös 150 mg/ml 200 ml Fl | 1 Stk | CHF 44.39 | CHF 64.70 | 01/01/2024 | B | 7680469690030 |
Limitation
No limitation is recorded on the SL for this preparation.
More preparations in this group
FAQ
Is Ultravist 150 covered by Swiss health insurance?
Yes. Ultravist 150 is on the FOPH Specialities List, so Swiss mandatory health insurance reimburses it within the authorised indication. You still pay the deductible and a co-payment of 10 per cent.
What does Ultravist 150 cost in Switzerland?
The public price is the maximum price set by the FOPH and for Ultravist 150 ranges from CHF 31.50 to CHF 64.70 per pack. The ex-factory price ranges from CHF 13.88 to CHF 44.39. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages